1. CS-05 Can systemic lupus erythematosus (SLE) disease activity be consistently scored and interpreted with simple, rapid outcome measures?. (August 2018) Authors: Askanase, Anca D; Thanou, Aikaterini; James, Judith A; Arriens, Cristina; Aberle, Teresa; Chakravarty, Eliza; Rawdon, Joe; Kamp, Stan; Stavrakis, Stavros; Merrill, Joan T Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 2 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0213 RANDOMIZED PLACEBO CONTROLLED TRIAL OF ABATACEPT FOR NON-ORGAN THREATENING SYSTEMIC LUPUS WITH BACKGROUND MEDICATIONS WITHDRAWN. (June 2019) Authors: Thanou, Aikaterini; Arriens, Cristina; Aberle, Teresa; Chakravary, Eliza; Vaseer, Samera; Rawdon, Joe; James, Judith A.; Merrill, Joan Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Issue 6 (June 2017) Authors: Merrill, Joan T.; Immermann, Fred; Whitley, Maryann; Zhou, Tianhui; Hill, Andrew; O'Toole, Margot; Reddy, Padmalatha; Honczarenko, Marek; Thanou, Aikaterini; Rawdon, Joe; Guthridge, Joel M.; James, Judith A.; Sridharan, Sudhakar Journal: Arthritis & rheumatology Issue: Volume 69:Issue 6(2017) Page Start: 1257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗